InnoCan Pharma (XCNQ:INNO) Change In Payables And Accrued Expense : C$0.23 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is InnoCan Pharma Change In Payables And Accrued Expense?

InnoCan Pharma's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was C$-0.11 Mil. It means InnoCan Pharma's Accounts Payable & Accrued Expense declined by C$0.11 Mil from Sep. 2023 to Dec. 2023 .

InnoCan Pharma's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was C$0.22 Mil. It means InnoCan Pharma's Accounts Payable & Accrued Expense increased by C$0.22 Mil from Dec. 2022 to Dec. 2023 .

InnoCan Pharma Change In Payables And Accrued Expense Historical Data

The historical data trend for InnoCan Pharma's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Change In Payables And Accrued Expense Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.25

0.61

-0.54

-0.10

0.22

InnoCan Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.14	0.29	-0.20	0.24	-0.11

InnoCan Pharma Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.23 Mil.

InnoCan Pharma Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma (XCNQ:INNO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

INNPF:USA IP4:Germany

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

InnoCan Pharma (XCNQ:INNO) Headlines

From GuruFocus

President of Innocap, Inc. is in Singapore

By Marketwired Marketwired • 05-03-2018

Innocap, Inc. Year End Message To Shareholders

By PRNewswire PRNewswire • 12-14-2020

Innocap, Inc. Current Activities - Salvage Ship Has Departed Singapore For Recovery Operations

By Marketwired Marketwired • 06-28-2018

President of Innocap, Inc. is in Singapore

By GlobeNewswire GlobeNewswire • 05-03-2018

Innocap, Inc.'s Current Activities

By Marketwired Marketwired • 05-24-2018

Unique Logistics Holdings, Inc. and Innocap, Inc. Complete Reverse Merger and Financing

By PRNewswire PRNewswire • 10-27-2020